150 related articles for article (PubMed ID: 8891902)
41. Correlation between lack of bone Gla protein mRNA expression in rat transplantable osteosarcomas and expression of both c-fos and c-jun proto-oncogenes.
Honoki K; Dohi Y; Tabata S; Mii Y; Miyauchi Y; Tsutsumi M; Tsujiuchi T; Morishita T; Miura S; Moriyama T
Mol Carcinog; 1993; 7(2):111-5. PubMed ID: 8457289
[TBL] [Abstract][Full Text] [Related]
42. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
Park HR; Park YK
J Korean Med Sci; 1995 Oct; 10(5):360-7. PubMed ID: 8750062
[TBL] [Abstract][Full Text] [Related]
43. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
[TBL] [Abstract][Full Text] [Related]
44. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.
Araki N; Uchida A; Kimura T; Yoshikawa H; Aoki Y; Ueda T; Takai S; Miki T; Ono K
Clin Orthop Relat Res; 1991 Sep; (270):271-7. PubMed ID: 1884549
[TBL] [Abstract][Full Text] [Related]
45. Mutational activation of ras genes is absent in pediatric osteosarcoma.
Antillón-Klüssmann F; García-Delgado M; Villa-Elízaga I; Sierrasesúmaga L
Cancer Genet Cytogenet; 1995 Jan; 79(1):49-53. PubMed ID: 7850751
[TBL] [Abstract][Full Text] [Related]
46. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
47. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
48. p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats.
Kido A; Tsujiuchi T; Tsutsumi M; Takahama M; Okajima E; Kobitsu K; Miyauchi Y; Mii Y; Tamai S; Konishi Y
Cancer Lett; 1997 Jan; 112(1):5-10. PubMed ID: 9029163
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of cellular oncogenes in human osteosarcomas transplanted into nude mice].
Asano S; Yamashita T
Nihon Seikeigeka Gakkai Zasshi; 1988 Mar; 62(3):231-42. PubMed ID: 3164747
[TBL] [Abstract][Full Text] [Related]
50. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
51. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
Li DC
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
[TBL] [Abstract][Full Text] [Related]
52. Oncogene alterations in rat colon tumors induced by N-methyl-N-nitrosourea.
Alexander RJ; Buxbaum JN; Raicht RF
Am J Med Sci; 1992 Jan; 303(1):16-24. PubMed ID: 1728873
[TBL] [Abstract][Full Text] [Related]
53. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
Lenos K; Grawenda AM; Lodder K; Kuijjer ML; Teunisse AF; Repapi E; Grochola LF; Bartel F; Hogendoorn PC; Wuerl P; Taubert H; Cleton-Jansen AM; Bond GL; Jochemsen AG
Cancer Res; 2012 Aug; 72(16):4074-84. PubMed ID: 22700878
[TBL] [Abstract][Full Text] [Related]
54. Effects of sulfur dioxide derivatives on expression of oncogenes and tumor suppressor genes in human bronchial epithelial cells.
Qin G; Meng Z
Food Chem Toxicol; 2009 Apr; 47(4):734-44. PubMed ID: 19167448
[TBL] [Abstract][Full Text] [Related]
55. Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.
Gokgoz N; Wunder JS; Mousses S; Eskandarian S; Bell RS; Andrulis IL
Cancer; 2001 Oct; 92(8):2181-9. PubMed ID: 11596036
[TBL] [Abstract][Full Text] [Related]
56. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
Kunimi K; Uchibayashi T; Hisazumi H
Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
[TBL] [Abstract][Full Text] [Related]
57. [Genetic alterations in the genesis and development of ovarian cancer].
Okamoto A; Yokoyama S; Terashima Y
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
[TBL] [Abstract][Full Text] [Related]
58. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
59. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
Maillet MW; Robinson RA; Burgart LJ
Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
[TBL] [Abstract][Full Text] [Related]
60. [A study on the transcriptional expression of oncogenes in human primary brain tumors].
Sun N; Wen Y; Yan S; Sun Z; Zhou R; Liao W
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Jun; 24(2):135-8. PubMed ID: 8244289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
